Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kodiak Sciences Inc. | 40,000 | reported | 30 Jun 2025 | tx 10+189,356 |
| MADRIGAL PHARMACEUTICALS, INC. | 26,097 | reported | 22 May 2026 | tx 101+160,040−125,630 |
| Protara Therapeutics, Inc. | 24,000 | reported | 12 Jun 2025 | tx 9+144,000 |
| INCYTE CORP | 20,863 | reported | 06 Jan 2016 | tx 154+1,429,305−1,673,842 |
| BRANDPARTNERS GROUP INC | 0 | reported | 08 Feb 2008 | tx 5+618,000−550,000 |
| CONSTELLATION PHARMACEUTICALS INC | 0 | reported | 15 Jul 2021 | tx 4+39,513−39,513 |
| Kiniksa Pharmaceuticals International, plc | 0 | reported | 01 Feb 2026 | tx 32+223,149−19,157 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 40 | 506.68 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 320 | 508.24 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 151 | 510.36 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 610 | 511.40 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 439 | 512.50 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 40 | 512.97 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 343 | 514.67 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 657 | 515.92 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 723 | 516.87 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,497 | 517.59 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 782 | 518.76 USD | 10b5-1 |
| 22 May 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 519.98 USD | 10b5-1 |
| 23 Feb 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 2,500 | 7.36 USD | |
| 23 Feb 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 2,500 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 683 | — | |
| 01 Feb 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 683 | 0.00 USD | deriv |
| 01 Feb 2026 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 683 | 0.00 USD | deriv |
| 26 Jan 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 4,000 | 16.46 USD | |
| 26 Jan 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | deriv |
| 13 Nov 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 146 | 514.67 USD | |
| 13 Nov 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 919 | 515.64 USD | |
| 13 Nov 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 645 | 517.51 USD | |
| 13 Nov 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 835 | 518.53 USD | |
| 13 Nov 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,355 | 519.67 USD | |
| 13 Nov 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 308 | 520.68 USD |
1 purchase reported after at least 12 months of silence — most recent on 20 Mar 2020.